Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,009,000 | 4,645,000 | 7,073,000 | 5,499,000 | 8,077,000 |
| Marketable Securities | 1,561,000 | 2,000,000 | 1,750,000 | 1,751,000 | 3,000 |
| Receivables | 8,191,000 | 8,255,000 | 7,943,000 | 7,931,000 | 8,221,000 |
| Inventories | 4,978,000 | 5,430,000 | 5,198,000 | 5,133,000 | 5,088,000 |
| Other current assets | 3,398,000 | 3,453,000 | 3,512,000 | 3,326,000 | 3,200,000 |
| TOTAL | $22,137,000 | $23,783,000 | $25,476,000 | $23,640,000 | $24,589,000 |
| Non-Current Assets | |||||
| PPE Net | 9,306,000 | 9,412,000 | 9,282,000 | 9,324,000 | 9,448,000 |
| Intangibles | 61,386,000 | 62,988,000 | 59,362,000 | 59,891,000 | 60,690,000 |
| Other Non-Current Assets | 4,492,000 | 4,180,000 | 4,377,000 | 4,241,000 | 3,999,000 |
| TOTAL | $75,184,000 | $76,580,000 | $73,021,000 | $73,456,000 | $74,137,000 |
| Total Assets | $97,321,000 | $100,364,000 | $98,496,000 | $97,095,000 | $98,726,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,079,000 | 2,606,000 | 2,547,000 | 2,555,000 | 2,872,000 |
| Accrued Expenses | 1,988,000 | 1,823,000 | 1,495,000 | 1,314,000 | 1,596,000 |
| Other current liabilities | 2,852,000 | 2,663,000 | 2,591,000 | 2,632,000 | 2,689,000 |
| TOTAL | $13,332,000 | $14,601,000 | $14,772,000 | $13,937,000 | $14,012,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,061,000 | 31,197,000 | 30,284,000 | 31,157,000 | 31,308,000 |
| Other Non-Current Liabilities | 4,116,000 | 4,470,000 | 4,500,000 | 4,682,000 | 4,784,000 |
| TOTAL | $34,438,000 | $36,790,000 | $36,306,000 | $37,654,000 | $37,990,000 |
| Total Liabilities | $47,770,000 | $51,392,000 | $51,077,000 | $51,591,000 | $52,002,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 377,261 | 382,500 | 381,996 | 381,716 | 381,312 |
| Common Shares | 444,000 | 444,000 | 443,000 | 443,000 | 442,000 |
| Retained earnings | 53,102,000 | 51,421,000 | 49,940,000 | 48,542,000 | 47,364,000 |
| Other shareholders' equity | -2,731,000 | -2,497,000 | -2,426,000 | -2,777,000 | -3,235,000 |
| TOTAL | $49,551,000 | $48,972,000 | $47,419,000 | $45,504,000 | $46,724,000 |
| Total Liabilities And Equity | $97,321,000 | $100,364,000 | $98,496,000 | $97,095,000 | $98,726,000 |